Most women who come in to FACE/FIT in their early to mid-forties aren’t saying “I think perimenopause is affecting my appearance.” They’re saying things like “my skin suddenly got so much drier,” “I’m losing hair and I don’t know why,” “my face looks deflated and I haven’t lost weight,” “the lines between my brows got so much deeper this year,” and “I’m gaining weight around my middle and nothing I do is touching it.”
All of those are perimenopause. And perimenopause starts earlier than most women expect, typically in the early to mid-forties, sometimes even the late thirties, well before periods become irregular and well before hot flashes arrive. The hormonal shifts that drive it begin quietly and the aesthetic consequences often show up years before anyone has used the word perimenopause in a doctor’s appointment.
This post explains what’s actually happening hormonally, how those changes show up in your face, skin, hair, and body, and what the evidence-based options are for addressing them, both from a medical standpoint and from an aesthetics standpoint. At FACE/FIT, we see this intersection constantly and we think women deserve a clear explanation rather than being told these changes are just part of getting older and there’s not much to be done.
What Perimenopause Actually Is
Perimenopause is the transition phase leading into menopause, defined medically as the period when ovarian hormone production begins to decline and become irregular. It ends at menopause itself, which is defined as twelve consecutive months without a period. The average age of menopause in the United States is 51, which means perimenopause commonly begins in the early to mid-forties, with some women experiencing it as early as their late thirties.
The hormonal picture during perimenopause is more complex than most people realize. It’s not a steady decline. Estrogen, progesterone, and testosterone levels fluctuate, sometimes dramatically, in patterns that vary between individuals. Estrogen in particular can spike and crash unpredictably before settling into a lower baseline. This fluctuation is what drives the variability of perimenopausal symptoms: why some months feel fine and others don’t, and why the changes in your face and body can seem inconsistent.
The hormones most relevant to aesthetic changes are estrogen, progesterone, and testosterone. Each affects the skin, hair, and body composition in specific ways and understanding what each does helps explain why the changes look the way they do.
What Estrogen Loss Does to Your Skin
Estrogen has a direct relationship with collagen production. Skin contains estrogen receptors, and when estrogen levels decline, collagen synthesis slows significantly. Research shows that women lose approximately 30 percent of their skin collagen in the first five years after menopause, with the most rapid loss occurring during perimenopause. This is not gradual and uniform. It’s accelerated.
The consequences are visible and specific:
Skin thinning: The skin becomes noticeably thinner as the dermal collagen matrix depletes. Thinner skin appears less plump, shows underlying structures more visibly, and bruises more easily.
Dryness and barrier compromise: Estrogen supports the skin’s moisture-retention mechanisms including the production of hyaluronic acid in the skin. As estrogen declines, the skin’s ability to retain hydration decreases, producing dryness, sensitivity, and a compromised barrier that makes the skin more reactive to products it previously tolerated.
Accelerated wrinkling: The loss of structural collagen combined with reduced skin elasticity produces more pronounced fine lines and allows existing expression lines to deepen faster than they would otherwise. Women often notice that lines they’d had for years suddenly seem deeper over a period of months during perimenopause. This is real and it’s estrogen-driven.
Slower wound healing: Estrogen supports cellular repair mechanisms. With lower estrogen, the skin’s recovery from treatments, UV damage, and daily environmental stress is slower.
For patients interested in addressing the hormonal driver directly, hormone optimization therapy replaces declining estrogen and has documented benefits for skin thickness, hydration, and collagen density. See our Hormone Optimization page.
What Happens to Your Face Shape During Perimenopause
This is the change that surprises women most because they don’t expect perimenopause to change the structure of their face, only their skin’s surface quality. But facial fat distribution is hormonally regulated, and as estrogen and progesterone decline, the fat pads that give the face its youthful structure shift and diminish.
The specific pattern: volume decreases in the upper face, particularly the temples and upper cheeks. The midface loses fullness. The lower face gains weight or appears heavier as fat redistribution favors the lower face and jowl area. This creates the characteristic change from a full upper face to a bottom-heavy appearance that patients describe as “my face looks tired” or “I look sad all the time” even when they’re not.
Simultaneously, bone density in the face decreases. The orbital rim around the eyes widens as the bone resorbs, enlarging the eye socket and contributing to the hollowed, tired appearance of the under-eye area. The jaw loses density too, which affects the structural support of the lower face.
This is not a skin problem. It’s a structural problem that requires structural solutions.
What helps: Facial balancing with dermal fillers restores volume to the areas that have deflated, creating a more even distribution that looks natural because it mirrors what was there before. Sculptra’s full-face collagen response addresses the diffuse volume loss that comes from both fat pad changes and dermal thinning simultaneously. Chin and jaw filler addresses the lower face structural changes. See our Facial Balancing, Cheek Fillers, and Sculptra pages for how we approach this.
Hair Thinning and Loss During Perimenopause
Hair thinning during perimenopause has two distinct drivers that often occur simultaneously, which is why it tends to feel more dramatic than expected.
The first driver is declining estrogen. Estrogen prolongs the anagen (growth) phase of the hair cycle. When estrogen falls, hairs spend less time in growth and more time in the shedding phase, producing increased daily shedding and reduced overall density over time.
The second driver is the relative increase in androgens (testosterone-like hormones) that occurs as estrogen declines. This androgen shift can trigger androgenetic alopecia, the pattern of diffuse thinning at the crown and temples that most people associate with male pattern baldness but affects a significant proportion of women during and after perimenopause.
These two mechanisms produce different patterns. Estrogen-related shedding tends to be diffuse across the whole scalp. Androgen-related thinning tends to concentrate at the part line, crown, and temples.
What helps: Scalp microneedling with PRP stimulates blood flow and growth factor activity in the follicle environment and has good clinical evidence for both estrogen-related and androgen-related hair thinning in women. A treatment series of three to four sessions spaced four to six weeks apart produces meaningful improvement in density for the majority of patients. See our Microneedling page for the Hair Rejuvenation protocol specifically.
Hormone optimization therapy addresses the hormonal driver directly by restoring estrogen and optimizing testosterone levels, which often produces noticeable improvement in hair density as one of its earliest and most appreciated effects. See our Hormone Optimization page.
Body Composition Changes
The weight gain pattern of perimenopause is specific and frustrating precisely because it doesn’t respond to the same interventions that worked before. Women who maintained their weight easily with diet and exercise in their thirties find that neither is working the way it used to, and that the distribution of weight has changed even when the total number on the scale hasn’t moved dramatically.
Estrogen influences where the body stores fat. In premenopausal women, estrogen promotes fat storage in the hips and thighs (subcutaneous fat). As estrogen declines, fat storage shifts toward the abdomen and visceral areas. This is metabolically different from the fat stored elsewhere and responds differently to both exercise and dietary intervention.
Simultaneously, declining estrogen and testosterone reduce lean muscle mass, which lowers the basal metabolic rate. This means the caloric intake that maintained a stable weight for years now produces gradual weight gain without any change in behavior.
What helps: GLP-1 medications including semaglutide and tirzepatide are particularly effective for the perimenopausal weight pattern because they address the metabolic driver rather than relying on willpower and restriction. The combination of appetite regulation and improved insulin sensitivity directly counteracts the hormonal shift that’s driving the change. See our Weight Management page.
Hormone optimization therapy addressing estrogen and testosterone deficiency also has documented effects on body composition, improving the muscle-to-fat ratio and making exercise more effective again. The two approaches work well together.
For patients dealing with skin laxity alongside weight changes, Attiva RF addresses the skin tightening component that GLP-1 weight loss can accelerate. See our post on skin changes after GLP-1 treatment for more detail.
Why This Happens Faster Than Expected
One of the most consistent things we hear from women in their early to mid-forties is that the changes happened quickly. In a relatively short period, multiple things shifted simultaneously and the cumulative effect felt sudden even though the underlying process had been building for years.
This is physiologically accurate. The accelerated collagen loss in the first years of declining estrogen, the simultaneous shift in fat distribution, the hair cycle changes, and the skin barrier compromise don’t happen on separate timelines. They’re all driven by the same hormonal shift and they tend to become visible around the same period.
Understanding this is genuinely useful because it changes how to think about the response. Treating these changes individually as isolated aesthetic concerns without addressing the hormonal context that’s driving them produces results that don’t hold as well and require more frequent intervention to maintain. Addressing the hormonal context alongside the aesthetic consequences produces better outcomes at every level.
The FACE/FIT Approach to Perimenopausal Patients
We approach perimenopausal patients as whole patients rather than as a collection of isolated aesthetic concerns. The face that’s lost volume and the skin that’s become drier and the hair that’s thinning and the weight that’s shifted are all expressions of the same underlying hormonal change. A treatment plan that addresses only the face while ignoring everything else produces a fraction of what a coordinated approach achieves.
In practice, a comprehensive perimenopausal consultation at FACE/FIT typically covers:
A hormonal assessment to understand where you are in the perimenopausal transition, what your hormone levels are doing, and whether hormone optimization therapy is appropriate and potentially the most impactful starting point.
A facial assessment looking at volume distribution, collagen quality, skin hydration, and specific concerns, with recommendations that address both immediate visible improvements and longer-term collagen restoration.
A skin quality assessment that accounts for the specific changes in barrier function, moisture retention, and healing capacity that occur during perimenopause and affects how treatments perform and recover.
A hair discussion if thinning is a concern, including whether scalp microneedling with PRP is appropriate and whether hormonal optimization is likely to help.
A body composition conversation if weight changes are a concern, and whether GLP-1 therapy, hormone optimization, or both are appropriate to address the metabolic driver.
Not every patient needs every element of this. The consultation is where we figure out what’s most relevant for you specifically and where to start.
Frequently Asked Questions
When does perimenopause typically start?
Perimenopause commonly begins in the early to mid-forties, but can start as early as the late thirties. The first signs are often changes in the menstrual cycle combined with the skin, hair, and mood changes described in this post. Many women are in perimenopause for several years before the diagnosis is made because the early symptoms are attributed to stress, lifestyle, or general aging rather than hormonal transition.
How do I know if what I'm experiencing is perimenopause versus just aging?
The two overlap significantly but the timeline and pattern offer clues. Changes that accelerate in your early to mid-forties, particularly involving skin quality, facial volume, hair density, and abdominal weight, are more likely to have a perimenopausal hormonal component than changes that develop gradually over decades. A hormone evaluation through lab work provides clarity.
Can aesthetic treatments fully address perimenopausal changes without hormone therapy?
They can address specific visible changes effectively and meaningfully. Fillers restore facial volume. Sculptra rebuilds collagen. Microneedling with PRP supports hair density. Attiva RF improves skin firmness. These treatments work well and produce real results without hormone therapy. However, without addressing the hormonal driver, the collagen loss and volume changes continue and the interval between treatments may shorten over time. Combining aesthetic treatments with hormone optimization produces more sustained outcomes.
Is hormone therapy safe?
Does testosterone matter for women during perimenopause?
Yes, significantly. Women produce testosterone in the ovaries and adrenal glands and it plays an important role in libido, energy, muscle maintenance, cognitive function, and mood. Testosterone declines during perimenopause alongside estrogen and progesterone. Many women find testosterone optimization to be one of the most impactful elements of a hormone therapy program for how they feel day to day.
At what point should I see someone about perimenopausal changes?
When the changes are bothering you enough to affect how you feel about yourself or how you function. There’s no specific threshold of severity that has to be crossed first. Some women want to address early changes proactively. Others prefer to wait until specific concerns feel significant enough to act on. Both are valid. The consultation is the right starting point either way.
Noticing changes you think might be perimenopausal and want to understand your options?
The consultation is where we figure that out honestly. Book at FACE/FIT Houston and we’ll assess the specific area you’re concerned about, tell you whether Kybella is the right tool, what a realistic treatment plan would look like, and whether any complementary treatments would improve your overall result.
